Navigation Links
Alan Ashworth to receive award for his breakthrough work in breast cancer
Date:4/22/2010

Molecular biologist Alan Ashworth, Ph.D., FRS, the director of the Breakthrough Breast Cancer Research Centre at the Institute of Cancer Research in London will receive the David T. Workman Memorial Award on May 17. The two-year grant of $50,000 from the Samuel Waxman Cancer Research Foundation will support Dr. Ashworth's work with PARP inhibitors in BRCA-mutated cancers.

"I'm both surprised and delighted that the Waxman Foundation has thought to honor me in this way," said Dr. Ashworth. "Recognition from your peers is incredibly important and I'm thrilled."

Dr. Ashworth helped discover the BRCA2 breast cancer gene in 1995. After realizing that BRCA-related cancers had a flawed DNA repair pathway, Dr. Ashworth and his team worked with a biotechnology company to study the use of PARP inhibitors to treat these cancers. They learned that BRCA-defective cancer cells were 1,000 times more sensitive to PARP inhibitors than cells that were normal. His lab is studying the use of PARP inhibitors to treat cancers such as endometrial cancer, ovarian cancer and breast cancer, including triple-negative breast cancer, which responds poorly to normal chemotherapy.

Speaking about Dr. Ashworth's research in triple-negative breast cancer, Samuel Waxman, M.D., the Scientific Director of the Waxman Foundation said it represents a contribution from a scientist unraveling a genomic defect in breast cancer that has resulted in a novel treatment for women who would otherwise have a poor prognosis.

Michael Nierenberg, the Chair of the Foundation added, "The Waxman Foundation is committed to bridging the gap between lab science and the patient. We are excited to help further the important work of Dr. Ashworth and his lab."

Recent recipients of the Workman Award include Stephen Baylin, M.D., and Peter Jones, Ph.D., in 2008 for the development of demethylating agents and epigenetic therapy for hematologic malignancies and Douglas Lowy, M.D., and John Schiller, Ph.D., in 2006 for their advance in preventing cervical cancer with the HPV vaccine.


'/>"/>

Contact: Jenny Song
jsong@waxmancancer.org
212-348-0136
Samuel Waxman Cancer Research Foundation
Source:Eurekalert

Related biology news :

1. Rutgers Genetics receives $7.8 million for autism research
2. Herr receives Heinz Award for Technology, the Economy and Employment
3. UCI receives $5M from Edwards Lifesciences
4. Yu receives research funding from the Wallace H. Coulter Foundation
5. UGA Odum School of Ecology professor receives grant to study West Nile Virus in NYC
6. UC Riverside biologist receives prestigious MacArthur Fellowship
7. UC Irvine receives $2.18M to explore nano advancements in DNA sequencing
8. Penn biochemist receives NIH New Innovators Award
9. NYUs Center for Genomics & Systems Biology receives $4.4 million NSF grant
10. K-State chemistry professor to receive Masao Horiba award
11. Einstein researcher receives NIH grant to explore epigenetic regulation of the human genome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... 2017  New research undertaken by Fit Small Business ... 1,000 participants were simply asked which office technology had they ... consider standard issue.  Insights on what will be ... from futurists and industry leaders including Penelope Trunk , ... Some of these findings included; ...
(Date:1/6/2017)...  SomaLogic announced today that it has agreed ... iCarbonX, the China -based company ... Health Ecosystem that can define each person,s ,digital ... behavioral and psychological data, the Internet and artificial ... will provide proteomics data and applications expertise to ...
(Date:12/22/2016)... , Dec. 20, 2016  As part of its ... the leading personal genetics company, recently released its latest children,s ... . The book focuses on the topics of inheritance and ... Science Standards (NGSS) taught in elementary school classrooms in the ... a series by illustrator Ariana Killoran , whose previous ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... , Jan 19, 2017 Research and Markets ... has announced the addition of the ... Application - Forecast to 2025" report to their offering. ... The report provides a detailed analysis on current and future ... till 2025, using estimated market values as the base numbers ...
(Date:1/19/2017)... 19, 2017  ArmaGen, Inc., today announced that ... as chief executive officer, as well as a ... to ArmaGen more than 17 years of executive ... of biotherapeutics and pharmaceuticals. "Mathias ... experience and skillset necessary to lead ArmaGen to ...
(Date:1/19/2017)... , ... January 19, 2017 , ... FireflySci Inc. is ... rate. The tremendous growth is accounted to two main factors. The first ... the expanding network of vendors supplying FireflySci products all around the world. , 2016 ...
(Date:1/19/2017)... PLAINVIEW, N.Y. , Jan. 18, 2017 ... pathology services, announces the formation of an Executive Committee ... 2017 and beyond. John Cucci , ... been promoted from Director of Business Development to ... in 2015, Mr. Cucci served in senior sales leadership ...
Breaking Biology Technology: